Oncology stewardship practice in the United States: A Hematology/Oncology Pharmacy Association national survey.

Autor: Banez MT; Department of Pharmaceutical Services, University of California, San Francisco, California, USA., Atienza S; Department of Pharmacy, Advocate Health Midwest, Milwaukee, Wisconsin, USA., Butts A; Department of Pharmacy, UK HealthCare, Lexington, Kentucky, USA., Derba M; Department of Pharmacy, Eastern Maine Medical Center, Bangor, Maine, USA., Dicke K; Department of Pharmacy, OhioHealth, Columbus, Ohio, USA., Haverstick K; Pharmacy and Therapeutics Service Line, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Heron BB; National Pharmacy Benefits Management, Hematology/Oncology, Department of Veterans Affairs, Hines, Illinois, USA., Cimino SK; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Loop MS; Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Auburn, Alabama, USA., Hough S; The US Oncology Network, McKesson Specialty Health, The Woodlands, Texas, USA., Merten JA; Chimeric Medical Communications, LLC, St Ansgar, Iowa, USA., Moore DC; Department of Pharmacy, Atrium Health Levine Cancer Institute, Charlotte, North Carolina, USA., Shah V; Department of Pharmacy, Mayo Clinic, Phoenix, Arizona, USA., Taucher KD; Department of Pharmacy, UCHealth, Aurora, Colorado, USA., Zhang JM; Department of Pharmacy, University of Chicago Medical Center, Chicago, Illinois, USA., Mahmoudjafari Z; University of Kansas Health System, Kansas City, Kansas, USA.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Aug 01, pp. 10781552241265280. Date of Electronic Publication: 2024 Aug 01.

Targeted Fibroblast Growth Factor Receptor (FGFR) Inhibition in Recurrent, Metastatic Anal Carcinoma: A Case Report.

Autor: Miranda KW; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Cimino SK; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN., Eng C; Department of Medicine, Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN. Electronic address: cathy.eng@vumc.org.

Publikováno v: Clinical colorectal cancer [Clin Colorectal Cancer] 2022 Sep; Vol. 21 (3), pp. 272-275. Date of Electronic Publication: 2022 Jan 20.

Safety considerations with new treatment regimens for anal cancer.

Autor: Cimino SK; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA., Ciombor KK; Department of Medicine: Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Chakravarthy AB; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Bailey CE; Department of Surgery: Division of Surgical Oncology and Endocrine Surgery, Vanderbilt University Medical Center, Nashville, TN, USA., Hopkins MB; Department of Surgery: Division of Colon and Rectal Surgery, Vanderbilt University Medical Center, Nashville, TN, USA., Geiger TM; Department of Surgery: Division of Colon and Rectal Surgery, Vanderbilt University Medical Center, Nashville, TN, USA., Hawkins AT; Department of Surgery: Division of Colon and Rectal Surgery, Vanderbilt University Medical Center, Nashville, TN, USA., Eng C; Department of Medicine: Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

Publikováno v: Expert opinion on drug safety [Expert Opin Drug Saf] 2021 Aug; Vol. 20 (8), pp. 889-902. Date of Electronic Publication: 2021 Apr 26.